medicares
Tender Performance & Track Record
Company Overview
Tender Performance
Data for 01 April 2024 to 30 October 2025
Total Bids / Contract Value
Qualified Bids / Q Rate
Total Wins / Win Value
Wins Rate / Q-W Rate
Detailed Performance Analysis
Tender Performance by Ministries
Name
Top Bid Competitors
Companies that frequently compete with you in the same tenders — ranked by their total win value.You applied for 192 bids — LIFE LINE PHARMACY appeared in 53 of them.
MEDICARES
MEDICARES
Transform Your Tender Process
Join thousands of businesses winning more tenders
Smart Alerts
Get AI-powered tender recommendations
Market Intel
Track competitor bidding patterns
Email Reports
Weekly detailed analytics reports
Download Hub
Export tender data in bulk format
Smart Tracking
Never miss important deadlines
& Much More...
Discover all premium features with your trial
"TendersAi transformed our bidding process. We've increased our win rate by 40% and saved countless hours."
Historical Performance
7-year trend analysis (2018-2025)
Company Overview (1 Apr 2018-31 Mar 2025))
Total Bids
254
Contract Value
₹4.28 Cr
L1 Bids
129
Recent Win Rate
50.7%
Performance Analytics
MEDICARES: Business Analysis and Strategic Outlook
MEDICARES has demonstrated a strong presence in the Indian government tender landscape, marked by a 50.74% win rate and strategic focus on key sectors. This comprehensive business analysis report provides an in-depth evaluation of MEDICARES's financial performance, competitive positioning, and strategic opportunities within the government procurement ecosystem. Our analysis incorporates a SWOT analysis and actionable recommendations to drive sustained growth and enhanced competitive advantage.
Executive Summary
MEDICARES exhibits a commendable government tender performance, characterized by a high win rate of 50.74%. The company has actively participated in 254 government tenders, securing 129 L1 positions, showcasing their competitive pricing strategy. While the company shows strong revenue growth in recent years, there are areas where further optimization can enhance profitability and market share. This report explores the strengths, weaknesses, opportunities, and threats (SWOT) facing MEDICARES, providing strategic recommendations to leverage its competitive advantages and mitigate potential risks within the dynamic pharmaceutical procurement sector.
Financial Performance
MEDICARES's financial performance in government tenders has been robust, with a notable increase in contract values over the past few years. This section analyzes key financial metrics, providing a clear understanding of the company's revenue generation and profitability trends.
Key Financial Statistics
- Total Contract Value: ₹4,27,82,682.0